NYMOX PHARMACEUTICAL CORPORATION Adjustments For Decrease Increase In Prepaid Expenses
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Decrease Increase In Prepaid Expenses of -$7.00 thousand for the 9-month period ending 2024-09-30, per its 6-K filed 2025-01-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in prepaid expenses for the quarter ending 2023-09-30 was -$499.00K.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in prepaid expenses for the quarter ending 2023-06-30 was $28.00K, a 72.82% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in prepaid expenses for the quarter ending 2023-03-31 was -$56.00K.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in prepaid expenses for the quarter ending 2022-12-31 was $119.00K, a 176.74% increase year-over-year.
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 3 month | Adjustments For Decrease Increase In Prepaid Expenses 6 month | Adjustments For Decrease Increase In Prepaid Expenses 9 month | Adjustments For Decrease Increase In Prepaid Expenses 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$7.00K 6-K · filed 2025-01-02 | |||
| 2023-09-30 | -$499.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-01-02 | -$471.00K derived: sum of 2 quarters · filed 2025-01-02 | -$527.00K 6-K · filed 2025-01-02 | -$408.00K derived: sum of 4 quarters · filed 2025-06-03 |
| 2023-06-30 | $28.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | -$28.00K 6-K · filed 2023-08-14 | $91.00K derived: sum of 3 quarters · filed 2025-06-03 | -$1.00K derived: sum of 4 quarters · filed 2025-06-03 |
| 2023-03-31 | -$56.00K 6-K · filed 2023-05-12 | $63.00K derived: sum of 2 quarters · filed 2025-06-03 | -$29.00K derived: sum of 3 quarters · filed 2025-06-03 | $74.00K derived: sum of 4 quarters · filed 2025-06-03 |
| 2022-12-31 | $119.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | $27.00K derived: sum of 2 quarters · filed 2025-06-03 | $130.00K derived: sum of 3 quarters · filed 2025-06-03 | $116.00K 20-F · filed 2025-06-03 |
| 2022-09-30 | -$92.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-15 | $11.00K derived: sum of 2 quarters · filed 2023-11-15 | -$3.00K 6-K · filed 2023-11-15 | $40.00K derived: sum of 4 quarters · filed 2024-08-29 |
| 2022-06-30 | $103.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-14 | $89.00K 6-K · filed 2023-08-14 | $132.00K derived: sum of 3 quarters · filed 2024-08-29 | $14.00K derived: sum of 4 quarters · filed 2024-08-29 |
| 2022-03-31 | -$14.00K 6-K · filed 2023-05-12 | $29.00K derived: sum of 2 quarters · filed 2024-08-29 | -$89.00K derived: sum of 3 quarters · filed 2024-08-29 | |
| 2021-12-31 | $43.00K derived: 20-F 12 month − 6-K/A 9 month · filed 2024-08-29 | -$75.00K derived: sum of 2 quarters · filed 2024-08-29 | $68.00K 20-F · filed 2024-08-29 | |
| 2021-09-30 | -$118.00K derived: 6-K/A 9 month − 6-K 6 month · filed 2022-11-16 | $25.00K 6-K/A · filed 2022-11-16 | ||
| 2021-06-30 | $143.00K 6-K · filed 2022-08-15 | |||
| 2020-12-31 | -$180.00K 20-F · filed 2023-05-02 |